Reducing perioperative myocardial infarction with anesthetic drugs and techniques

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

BACKGROUND: Until now no randomized trial can be considered powered enough to show a reduction on both perioperative myocardial infarction and mortality. METHODS: We performed an extensive research of the literature to identify dugs or technique that could have an effect on perioperative myocardial infarction in cardiac and non-cardiac surgery. RESULTS: Volatile agents reduce myocardial infarction (NNT=37) and mortality (NNT=83) in cardiac surgery when compared to total intravenous anesthesia. No data regarding the use of volatile agents in non-cardiac surgery exists. Levosimendan reduces myocardial infarction (NNT=21) and mortality (NNT=12) in cardiac surgery when compared to placebo or other inotropic agents. No data regarding its use in non-cardiac surgery exists. Epidural analgesia has promising beneficial effects in both cardiac and non-cardiac surgery. In non-cardiac surgery statins and calcium antagonists have minor beneficial effects while alpha(2) agonists could reduce perioperative myocardial infarction and are included in the American College of Cardiology/American Heart Association Guidelines. Beta blockers are also included in the international guidelines but benefits and hazards should be careful considered. CONCLUSIONS: Volatile agents and levosimendan consistently reduce perioperative myocardial infarction and mortality in cardiac surgery but they have not been properly studied in non-cardiac surgery. Minor (epidural analgesia, statins, calcium antagonists and alpha(2) agonists) or doubtful (beta-blockers) results were found in non-cardiac surgery.

Original languageEnglish
Pages (from-to)858-862
Number of pages5
JournalCurrent Drug Targets
Volume10
Issue number9
DOIs
Publication statusPublished - 2009

Fingerprint

Surgery
Anesthetics
Myocardial Infarction
Thoracic Surgery
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Epidural Analgesia
Mortality
Guidelines
Calcium
Intravenous Anesthesia
Placebos
Hazards
Research

Keywords

  • Anaesthesia
  • Levosimendan
  • Mortality
  • Myocardial infarction
  • Outcome
  • Surgery
  • Volatile anaesthetics

ASJC Scopus subject areas

  • Drug Discovery
  • Pharmacology
  • Clinical Biochemistry
  • Molecular Medicine

Cite this

Reducing perioperative myocardial infarction with anesthetic drugs and techniques. / Landoni, G.; Zambon, M.; Zangrillo, A.

In: Current Drug Targets, Vol. 10, No. 9, 2009, p. 858-862.

Research output: Contribution to journalArticle

@article{9dd3b06f4adf418a9afdd0c4da42c0e1,
title = "Reducing perioperative myocardial infarction with anesthetic drugs and techniques",
abstract = "BACKGROUND: Until now no randomized trial can be considered powered enough to show a reduction on both perioperative myocardial infarction and mortality. METHODS: We performed an extensive research of the literature to identify dugs or technique that could have an effect on perioperative myocardial infarction in cardiac and non-cardiac surgery. RESULTS: Volatile agents reduce myocardial infarction (NNT=37) and mortality (NNT=83) in cardiac surgery when compared to total intravenous anesthesia. No data regarding the use of volatile agents in non-cardiac surgery exists. Levosimendan reduces myocardial infarction (NNT=21) and mortality (NNT=12) in cardiac surgery when compared to placebo or other inotropic agents. No data regarding its use in non-cardiac surgery exists. Epidural analgesia has promising beneficial effects in both cardiac and non-cardiac surgery. In non-cardiac surgery statins and calcium antagonists have minor beneficial effects while alpha(2) agonists could reduce perioperative myocardial infarction and are included in the American College of Cardiology/American Heart Association Guidelines. Beta blockers are also included in the international guidelines but benefits and hazards should be careful considered. CONCLUSIONS: Volatile agents and levosimendan consistently reduce perioperative myocardial infarction and mortality in cardiac surgery but they have not been properly studied in non-cardiac surgery. Minor (epidural analgesia, statins, calcium antagonists and alpha(2) agonists) or doubtful (beta-blockers) results were found in non-cardiac surgery.",
keywords = "Anaesthesia, Levosimendan, Mortality, Myocardial infarction, Outcome, Surgery, Volatile anaesthetics",
author = "G. Landoni and M. Zambon and A. Zangrillo",
year = "2009",
doi = "10.2174/138945009789108837",
language = "English",
volume = "10",
pages = "858--862",
journal = "Current Drug Targets",
issn = "1389-4501",
publisher = "Bentham Science Publishers B.V.",
number = "9",

}

TY - JOUR

T1 - Reducing perioperative myocardial infarction with anesthetic drugs and techniques

AU - Landoni, G.

AU - Zambon, M.

AU - Zangrillo, A.

PY - 2009

Y1 - 2009

N2 - BACKGROUND: Until now no randomized trial can be considered powered enough to show a reduction on both perioperative myocardial infarction and mortality. METHODS: We performed an extensive research of the literature to identify dugs or technique that could have an effect on perioperative myocardial infarction in cardiac and non-cardiac surgery. RESULTS: Volatile agents reduce myocardial infarction (NNT=37) and mortality (NNT=83) in cardiac surgery when compared to total intravenous anesthesia. No data regarding the use of volatile agents in non-cardiac surgery exists. Levosimendan reduces myocardial infarction (NNT=21) and mortality (NNT=12) in cardiac surgery when compared to placebo or other inotropic agents. No data regarding its use in non-cardiac surgery exists. Epidural analgesia has promising beneficial effects in both cardiac and non-cardiac surgery. In non-cardiac surgery statins and calcium antagonists have minor beneficial effects while alpha(2) agonists could reduce perioperative myocardial infarction and are included in the American College of Cardiology/American Heart Association Guidelines. Beta blockers are also included in the international guidelines but benefits and hazards should be careful considered. CONCLUSIONS: Volatile agents and levosimendan consistently reduce perioperative myocardial infarction and mortality in cardiac surgery but they have not been properly studied in non-cardiac surgery. Minor (epidural analgesia, statins, calcium antagonists and alpha(2) agonists) or doubtful (beta-blockers) results were found in non-cardiac surgery.

AB - BACKGROUND: Until now no randomized trial can be considered powered enough to show a reduction on both perioperative myocardial infarction and mortality. METHODS: We performed an extensive research of the literature to identify dugs or technique that could have an effect on perioperative myocardial infarction in cardiac and non-cardiac surgery. RESULTS: Volatile agents reduce myocardial infarction (NNT=37) and mortality (NNT=83) in cardiac surgery when compared to total intravenous anesthesia. No data regarding the use of volatile agents in non-cardiac surgery exists. Levosimendan reduces myocardial infarction (NNT=21) and mortality (NNT=12) in cardiac surgery when compared to placebo or other inotropic agents. No data regarding its use in non-cardiac surgery exists. Epidural analgesia has promising beneficial effects in both cardiac and non-cardiac surgery. In non-cardiac surgery statins and calcium antagonists have minor beneficial effects while alpha(2) agonists could reduce perioperative myocardial infarction and are included in the American College of Cardiology/American Heart Association Guidelines. Beta blockers are also included in the international guidelines but benefits and hazards should be careful considered. CONCLUSIONS: Volatile agents and levosimendan consistently reduce perioperative myocardial infarction and mortality in cardiac surgery but they have not been properly studied in non-cardiac surgery. Minor (epidural analgesia, statins, calcium antagonists and alpha(2) agonists) or doubtful (beta-blockers) results were found in non-cardiac surgery.

KW - Anaesthesia

KW - Levosimendan

KW - Mortality

KW - Myocardial infarction

KW - Outcome

KW - Surgery

KW - Volatile anaesthetics

UR - http://www.scopus.com/inward/record.url?scp=70450189802&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70450189802&partnerID=8YFLogxK

U2 - 10.2174/138945009789108837

DO - 10.2174/138945009789108837

M3 - Article

C2 - 19538174

AN - SCOPUS:70450189802

VL - 10

SP - 858

EP - 862

JO - Current Drug Targets

JF - Current Drug Targets

SN - 1389-4501

IS - 9

ER -